(NASDAQ: QURE) Uniqure Nv's forecast annual revenue growth rate of 150.88% is forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 30.73%, and it is also forecast to beat the US market's average forecast revenue growth rate of 14.13%.
Uniqure Nv's revenue in 2026 is $18,672,000.On average, 16 Wall Street analysts forecast QURE's revenue for 2026 to be $1,792,636,185, with the lowest QURE revenue forecast at $1,114,856,974, and the highest QURE revenue forecast at $3,423,232,432. On average, 16 Wall Street analysts forecast QURE's revenue for 2027 to be $5,642,610,784, with the lowest QURE revenue forecast at $978,898,806, and the highest QURE revenue forecast at $12,957,645,762.
In 2028, QURE is forecast to generate $22,956,814,051 in revenue, with the lowest revenue forecast at $5,941,371,921 and the highest revenue forecast at $40,867,915,294.